Dublin, Aug. 28, 2017 -- The "Worldwide Aortic Aneurysm Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.
The Global Aortic Aneurysm Market is estimated to witness a CAGR of 6.6% during the forecast period 2017-2023. The aortic aneurysm market is analyzed based on three segments - type, product types, and regions.
The increasing lifestyle diseases and smoking population are the factors that increase the chances for aortic aneurysm. Along with this, the growing aging population, favorable reimbursement, and technological advancements in products are driving the growth of the aortic aneurysm market. However, lack of awareness about the disease, stringent regulatory approval procedures, and risk associated with the procedure are hampering the growth of the market. The main unmet need in the market is endoleaking, which increases the mortality rate.
Currently, the market players are developing technologically advanced stent grafts for the treatment of complex aortic aneurysm repairs. The EVAR segment contributed more than 70% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the aortic aneurysm market in the future.
The market of aortic aneurysm is dominated by Cook Medical, Medtronic PLC, and W.L. Gore and Associates, who occupy around 85% of the market share. Other small players are adopting various strategies to increase their market share. Endologix acquired Trivascular to expand its product portfolio, thereby being able to address the current and future needs in the aortic aneurysm market.
In countries such as Australia, Germany, the US, and Switzerland, who have fee-for-service reimbursement system, the proportion undergoing AAA repair is higher compared with countries, such as Iceland, Sweden, Denmark, New Zealand, Hungary and Norway, who have a population-based reimbursement model.
Key Topics Covered:
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Stents
3.3.3 Angioplasty
4 Market Outlook
4.1 Market Definition
4.2 Importance of Aortic Aneurysm Repair Devices
4.3 Complications of Aortic Aneurysm
4.4 Risk Factors for Aortic Aneurysm
4.5 Types of Aneurysm
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 Evolution
5.2 Symptoms of Aortic Aneurysm
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising geriatric population
5.3.1.2 High prevalence of tobacco smoking
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.1.4 Favorable reimbursement conditions
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Mergers & acquisitions
5.3.2.3 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 Risk associated with the procedure
5.3.3.3 Lack of awareness
5.4 DRO - Impact Analysis
5.5 Key Stakeholders
6 Types: Market Size and Analysis
6.1 Overview
6.2 Abdominal Aortic Aneurysm
6.2.1 Procedure Type
6.2.1.1 Open surgery
6.2.1.2 Abdominal endovascular aneurysm repair
6.2.2 Location Types
6.3 Thoracic Aortic Aneurysm
6.3.1 Procedure Type
6.3.1.1 Open surgery
6.3.1.2 Thoracic endovascular aortic aneurysm
6.3.2 Location Types
7 Products: Market Size and Analysis
7.1 Overview
7.2 Stent Grafts
7.3 Catheters
7.4 Others
8 Regions: Market Size and Analysis
9 Competitive Landscape
9.1 Overview
10 Vendors Profile
10.1 MicroPort Scientific Corporation
10.2 Medtronic Plc
10.3 Terumo Corp.
10.4 Endologix Inc.
11 Companies to Watch For
11.1 Cook Medical Inc.
11.2 W.L. Gore & Associates
11.3 Maquet GmbH (Getinge Group)
11.4 Jotec GmbH
11.5 Boston Scientific Corp.
11.6 Lombard Medical Technologies PLC
For more information about this report visit https://www.researchandmarkets.com/research/t9xp3n/worldwide_aortic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



